Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI

Citations Over TimeTop 10% of 2023 papers

Abstract

Early assessment of neoadjuvant systemic therapy (NAST) response for triple-negative breast cancer (TNBC) is critical for patient care in order to avoid the unnecessary toxicity of an ineffective treatment. We assessed functional tumor volumes (FTVs) from dynamic contrast-enhanced (DCE) MRI after 2 cycles (C2) and 4 cycles (C4) of NAST as predictors of response in TNBC. A group of 100 patients with stage I-III TNBC who underwent DCE MRI at baseline, C2, and C4 were included in this study. Tumors were segmented on DCE images of 1 min and 2.5 min post-injection. FTVs were measured using the optimized percentage enhancement (PE) and signal enhancement ratio (SER) thresholds. The Mann-Whitney test was used to compare the performance of the FTVs at C2 and C4. Of the 100 patients, 49 (49%) had a pathologic complete response (pCR) and 51 (51%) had a non-pCR. The maximum area under the receiving operating characteristic curve (AUC) for predicting the treatment response was 0.84 (p p < 0.001). The FTV measured at baseline was not able to discriminate pCR from non-pCR. FTVs measured on DCE MRI at C2, as well as at C4, of NAST can potentially predict pCR and non-pCR in TNBC patients.

Related Papers

• → Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy(2016)17 cited
• → MR-tomographische Charakteri-sierung suspekter Mammabefunde mittels suszeptibilitätsgewichteter T2*-Sequenzen(2001)5 cited
• → Three Cases of Hemorrhagic Hepatic Cyst with a Characteristic Contrast Pattern Observed Using Dynamic CT and MRI(2014)2 cited
• → Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0T: a pilot study(2016)
• → Volumetric kinetic assessment in dynamic contrast enhanced-MRI (DCE-MRI) of breast cancer: A new method for evaluation of whole tumor enhancing pattern (P. 47)(2020)